The dramatic drop in measles deaths globally since 2000 is a testament to the power of vaccines, yet the sharp rise in cases in recent years poses a serious challenge to public health. According to a recent World Health Organization (WHO) report, death rates from measles have plummeted by 88% between 2000 and 2024, largely due to widespread vaccination efforts. This remarkable progress has saved nearly 59 million lives in less than a quarter-century, a staggering achievement. But here’s where it gets controversial: in 2024 alone, measles still infected an estimated 11 million people worldwide, revealing glaring vulnerabilities in immunisation coverage.
The report reveals that approximately 95,000 people—mostly children younger than five—succumbed to measles in 2024. Although this number represents one of the lowest annual death tolls in over two decades, WHO insists that any death from a disease that could be prevented through a safe, effective, and cheap vaccine is unacceptable. “Measles is the world’s most contagious virus,” WHO Director-General Tedros Ghebreyesus emphasized, “and these figures show how it ruthlessly exploits even the smallest gaps in our defenses.” His message underlines a crucial point: measles does not respect national borders. When vaccination coverage is comprehensive—reaching every child in every community—expensive outbreaks can be prevented, and entire countries can wipe out the disease.
Despite the decline in deaths, measles infections soared sharply in many regions during 2024. The WHO noted jumps of 86% in the Eastern Mediterranean, 47% in Europe, and 42% in South-East Asia compared to 2019 levels. In stark contrast, the African Region experienced a 40% drop in cases and a 50% fall in deaths, improvements credited to stronger immunisation programs. It’s a complex picture: while some areas see more infections, better healthcare access and nutrition help reduce fatalities. But measles remains far from harmless. It can trigger severe lifelong effects such as blindness, pneumonia, and encephalitis—a brain infection causing swelling and permanent neurological damage.
One of the central concerns in the WHO report is the still insufficient immunisation coverage worldwide. Experts stress that to halt measles transmission, vaccination must reach at least 95% of children with two doses. Yet, last year, over 30 million children missed adequate protection. The majority live in Africa and the Eastern Mediterranean regions, where ongoing conflict, fragile health systems, and humanitarian crises hinder routine vaccinations. WHO also praised improved surveillance efforts; more than 760 laboratories tested half a million samples in 2024, marking a 27% increase from the previous year. Still, there’s worry that recent funding cuts could jeopardize this essential progress.
When it comes to eliminating measles altogether, WHO is cautious. As of the end of 2024, only 81 countries—42% of the global total—had reached elimination status, barely three more than before the pandemic. Noteworthy progress has come in the Pacific and parts of Africa, where Cabo Verde, Mauritius, and Seychelles recently confirmed elimination, the first African countries to do so. Yet, in many high-income nations that once controlled the virus, measles has bounced back because vaccination rates fell below the critical 95% threshold. WHO is calling for robust political will, sustained funding, and the ability to detect and respond quickly to outbreaks. In places with weak routine immunisation services, well-run, high-coverage vaccination campaigns remain crucial.
The Vaccine Alliance, Gavi, responded to the WHO findings by highlighting measles vaccination as one of the most successful public health interventions ever, credited with preventing 58.7 million deaths since 2000. Beyond health benefits, Gavi emphasized the economic advantage, estimating a return of $58 for every $1 invested. Since 2007, Gavi has put $2.2 billion into supporting measles and rubella shots in 57 lower-income countries, reaching over 1.3 billion children worldwide. In 2024, Gavi helped deliver catch-up and follow-up vaccine campaigns in 24 countries, reaching upwards of 62 million children, and responded to outbreaks in five countries that protected nearly 7 million kids. African nations, in particular, have made notable gains in immunisation despite challenges like limited resources, growing birth rates, and competing health issues. First-dose measles coverage rose from 50% in 2000 to 71% in 2024, and the second dose climbed from 5% to 55% during the same period, resulting in a 40% fall in measles cases and a 50% drop in deaths since 2019. Still, Gavi’s Head of Measles and Rubella Vaccines, Rebecca Casey, cautioned that gaps in coverage leave millions vulnerable, especially the most marginalized. “The rise in cases and outbreaks is a stark reminder that complacency can be deadly,” she warned. “Every child deserves protection from measles.”
In a related but hopeful note, Nigeria—the continent’s most populous country—launched an extensive integrated vaccination campaign in November 2025, targeting multiple diseases including measles, rubella, polio, and HPV. Coordinated by the National Primary Health Care Development Agency (NPHCDA) and supported by WHO, Gavi, UNICEF, and others, the campaign aims to immunize approximately 106 million children across Nigeria’s 36 states and the Federal Capital Territory. The first phase covered 11 states plus the FCT, and the second phase targeted an additional nine northern and northeastern states. By October 30, preliminary results reported more than 58.9 million children vaccinated against measles and rubella—a massive step forward in disease control.
This ongoing battle against measles reveals a paradox: immense success in saving lives but also serious setbacks due to uneven vaccine coverage and health system challenges. Is the world truly prepared to close the immunisation gaps and prevent measles from exploiting every weakness? Does the resurgence in wealthy countries signal complacency that could undermine global progress? These questions deserve urgent attention and public discussion. What are your thoughts? Is enough being done to protect every child, or are the current efforts falling short of what’s needed to finally eliminate measles worldwide?
